公开(公告)号：US20180303817A1

公开(公告)日：2018-10-25

申请号：US15771193

申请日：2016-12-15

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Saori Miyano ,  Yuji Yamamoto ,  Takayuki Nakagawa

IPC: A61K31/4545 ,  A61P35/04

CPC classification number: A61K31/4545 ,  A61P35/04

Abstract: The present application discloses a therapeutic agent for breast cancer, comprising 5-((2-(4-(1-(2-hydroxyethyl)piperidin-4-yl)benzamide)pyridin-4-yl)oxy)-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide or a pharmacologically acceptable salt thereof.

公开(公告)号：US20160089365A1

公开(公告)日：2016-03-31

申请号：US14862349

申请日：2015-09-23

Applicant: Eisai R&D Management Co., Ltd.

Inventor： Yu Kato ,  Sho Tachino ,  Takayuki Nakagawa ,  Kimiyo Tabata ,  Kiyoshi Okamoto ,  Yusaku Hori

IPC: A61K31/47

CPC classification number: A61K31/47

Abstract: An immunostimulatory compound is disclosed.

Abstract translation: 公开了免疫刺激化合物。